14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score -1.113 4 days ( -15.12 % )
Last Price $3.35 5.68 %
High/ Low $2.96 - $3.36 17.26%
Chg 7 Days 17.54 % $2.85 $3.35
Chg 30 Days -15.40 % $3.96 $3.35
Chg 12 mos -28.42 % $4.68 $3.35
Trend - 3 mos 41.94 % Width: 64.76 %
Trend - 12 mos -38.81 % Width: 881.05 %
Pred. range - 3 mos $4.15 - $6.84 23.86 % - 104.08 %
Pred. range - 12 mos N/A - $2.77 -100.00 % - -17.22 %
Short MA avg 3 mos Buy May 01, 2024 - 4 days
Long MA avg 3 mos Sell Apr 15, 2024 - 16 days
Short/Long MA avg 3 mos Sell Apr 18, 2024 - 13 days
Short MA avg 12 mos Buy May 03, 2024 - 2 days
Long MA avg 12 mos Sell Feb 12, 2024 - 59 days
Short/Long MA avg 12 mos Buy Feb 15, 2024 - 56 days
Pivot Short Sell Apr 08, 2024 - 21 days
Bollinger Buy Feb 26, 2024 - 50 days
MACD Sell No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Generation Bio Co.

Generation Bio Co. Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. ... GBIO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT